Dexmethylphenidate: A Viewpoints

Drugs

Volumn 62, Issue 13, 2002, Pages 1905-

  Stein, Mark A ^a   Eugene Arnold, L ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; METHYLPHENIDATE; UNCLASSIFIED DRUG;

ANOREXIA; ATTENTION DEFICIT DISORDER; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; HUMAN; INSOMNIA; ISOMER; NOTE; PATIENT COMPLIANCE; SCHOOL CHILD; STRUCTURE ACTIVITY RELATION; TIC; TREATMENT INDICATION;

EID: 0036385618     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262130-00010     Document Type: Note

References (4)

1. Isomer isolation leads researchers to more effective psychiatric drugs. Psychiatr News 2001 Dec 21; 36 (24): 17
2. Srinivas NR, Hubbard JW, Quinn D, et al. Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharamcol Ther 1992 Nov; 52: 561-8
3. Kimko HC, Cross JT, Abernethy DR. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet 1999 Dec; 6: 457-70
4. Dexmethylphenidate (Focalin) for ADHD. Medical Letter 2002; 44 (1130): 45-6